Clinical Trials Directory

Trials / Completed

CompletedNCT01232049

Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

A Randomized, Open-label, Multiple Dose, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Pitavastatin and Valsartan in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate a pharmacokinetic drug interaction and safety between Pitavastatin and Valsartan in healthy male subjects

Conditions

Interventions

TypeNameDescription
DRUGMultiple Oral Dose ofPitavastatin 4mg
DRUGMultiple Oral Dose ofValsartan 320mg

Timeline

Start date
2010-10-01
Primary completion
2011-03-01
First posted
2010-11-02
Last updated
2011-06-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01232049. Inclusion in this directory is not an endorsement.